Concurrent Targeting of Vasopressin Receptor 2 and Somatostatin Receptors in Autosomal Dominant Polycystic Kidney Disease: A Promising Approach for Autosomal Dominant Polycystic Kidney Disease Treatment?

被引：1
作者：
Hogan, Marie C. [1 ,2 ]
Masyuk, Tatyana V. [3 ,4 ]
机构：
[1] Mayo Clin, Coll Med & Sci, Div Nephrol & Hypertens, Rochester, MN USA
[2] Mayo Clin, Coll Med & Sci, Robert M & Billie Kelley Pirnie Translat Polycyst, Rochester, MN USA
[3] Mayo Clin, Coll Med & Sci, Div Gastroenterol & Hepatol, Rochester, MN USA
[4] Mayo Clin, Coll Med & Sci, Ctr Basic Res Digest Dis, Rochester, MN USA
来源：
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY | 2023年 / 18卷 / 02期
关键词：
TOLVAPTAN; EFFICACY;
D O I：
10.2215/CJN.0000000000000055
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
[No abstract available]
引用
收藏
页码：154 / 156
页数：3
相关论文
共 50 条
  • [41] Radiographic Imaging in Autosomal Dominant Polycystic Kidney Disease: A Claims Analysis
    Aigbogun, Myrlene Sanon
    Stellhorn, Robert A.
    Pao, Christina S.
    Seliger, Stephen L.
    INTERNATIONAL JOURNAL OF NEPHROLOGY AND RENOVASCULAR DISEASE, 2021, 14 : 133 - 142
  • [42] The wind of change in the management of autosomal dominant polycystic kidney disease in childhood
    Charlotte Gimpel
    Carsten Bergmann
    Djalila Mekahli
    Pediatric Nephrology, 2022, 37 : 473 - 487
  • [43] Drug Development in Autosomal Dominant Polycystic Kidney Disease: Opportunities and Challenges
    Chebib, Fouad T.
    Perrone, Ronald D.
    ADVANCES IN KIDNEY DISEASE AND HEALTH, 2023, 30 (03): : 261 - 284
  • [44] Citrate in autosomal dominant polycystic kidney disease: biomarker or therapeutic agent?
    Rocha, Daniel Ribeiro
    Matos, Ana Cristina Carvalho
    Heilberg, Ita Pfeferman
    CURRENT OPINION IN NEPHROLOGY AND HYPERTENSION, 2025, 34 (02) : 138 - 142
  • [45] A Provincial Survey of the Contemporary Management of Autosomal Dominant Polycystic Kidney Disease
    Yi, Tae Won
    Levin, Adeera
    Bevilacqua, Micheli
    Canney, Mark
    CANADIAN JOURNAL OF KIDNEY HEALTH AND DISEASE, 2020, 7
  • [46] Autosomal Dominant Polycystic Kidney Disease: Clinical Assessment of Rapid Progression
    Furlano, Monica
    Loscos, Irene
    Marti, Teresa
    Bullich, Gemma
    Ayasreh, Nadia
    Rius, Asuncion
    Roca, Lourdes
    Ballarin, Jose
    Ars, Elisabet
    Torra, Roser
    AMERICAN JOURNAL OF NEPHROLOGY, 2018, 48 (04) : 308 - 317
  • [47] Metabolism-based approaches for autosomal dominant polycystic kidney disease
    Bakaj, Ivona
    Pocai, Alessandro
    FRONTIERS IN MOLECULAR BIOSCIENCES, 2023, 10
  • [48] Patient-Reported Outcomes Measures, Polycystic Kidney Disease Burden, and Outcomes in Autosomal Dominant Polycystic Kidney Disease
    Oberdhan, Dorothee
    Yarlas, Aaron
    Bjorner, Jakob B.
    Krasa, Holly
    KIDNEY MEDICINE, 2024, 6 (01)
  • [49] Management of autosomal dominant polycystic kidney disease in the era of disease-modifying treatment options
    Radhakrishnan, Yeshwanter
    Duriseti, Parikshit
    Chebib, Fouad T.
    KIDNEY RESEARCH AND CLINICAL PRACTICE, 2022, 41 (04) : 422 - 431
  • [50] The Longitudinal Study of Liver Cysts in Patients With Autosomal Dominant Polycystic Kidney Disease and Polycystic Liver Disease
    Matsuura, Ryo
    Honda, Kenjiro
    Hamasaki, Yoshifumi
    Doi, Kent
    Noiri, Eisei
    Nangaku, Masaomi
    KIDNEY INTERNATIONAL REPORTS, 2017, 2 (01): : 60 - 65
12345